Universities of Cologne
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1388-01-01
- Employees
- 251
- Market Cap
- -
Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma
Phase 2
Not yet recruiting
- Conditions
- Hodgkin Lymphoma (Category)
- Interventions
- Drug: BrECADD
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 35
- Registration Number
- NCT06919679
Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin Lymphoma
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 50
- Registration Number
- NCT06916416
A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis
Recruiting
- Conditions
- Extrapulmonary Tuberculosis
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 150
- Registration Number
- NCT06875336
- Locations
- 🇩🇪
University Hospital Bonn, Bonn, Germany
🇩🇪Research Center Borstel, Borstel, Germany
🇩🇪University Hospital of Cologne, Cologne, Germany
Analysis of the Epidemiology, Clinical Presentation and Therapy as Well as Therapy-associated Risk of Demyelination Syndrome in Patients With Profound Hyponatremia in the Emergency Department
Recruiting
- Conditions
- Hyponatremia
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 1000
- Registration Number
- NCT06781710
- Locations
- 🇩🇪
University Hospital of Cologne, Cologne, Germany
Vaccine-induced Immunity in Immunocompromised Patients
Recruiting
- Conditions
- Immunodeficiency
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 5000
- Registration Number
- NCT06612515
- Locations
- 🇩🇪
University Hospital Cologne, Cologne, NRW, Germany
IMPLEMENT - Model Project for Quality-assured Exercise Therapy for Cancer Patients
Not Applicable
Recruiting
- Conditions
- Cancer
- Interventions
- Other: Cancer Patients; Institutions and their employees in the treatment and/or counseling of cancer patients
- First Posted Date
- 2024-07-11
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 600
- Registration Number
- NCT06496711
- Locations
- 🇩🇪
University Hospital Cologne, Cologne, Germany
Causes, Characteristics and Treatment of Hypercalcemia in the Emergency Room of a German Hospital
Active, not recruiting
- Conditions
- Hypercalcemia
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 200
- Registration Number
- NCT06467877
- Locations
- 🇩🇪
Department II of Internal Medicine,University of Cologne, Cologne, Germany
Trial Comparing Cataract Surgery with Triple-DMEK in Patients with Cataract and Fuchs Endothelial Corneal Dystrophy
Not Applicable
Recruiting
- Conditions
- Cataract and Fuchs Endothelial Corneal DystrophyCataract Surgery
- Interventions
- Procedure: Intervention group /arm 1 (Cataract surgery alone)
- First Posted Date
- 2024-05-22
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 120
- Registration Number
- NCT06425666
- Locations
- 🇩🇰
Department of Ophthalmology, Aarhus University Hospital, Aarhus N, Midtjylland, Denmark
🇩🇪Klinik für Ophthalmologie des Universitätsklinikums Köln, Köln, NRW, Germany
🇳🇱Radboud-Universität Nijmegen, Nijmegen, Gelderland, Netherlands
Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)
- First Posted Date
- 2024-05-17
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 29
- Registration Number
- NCT06419179
- Locations
- 🇩🇪
University Hospital Cologne, Cologne, North Rhine-Westphalia, Germany
Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients
Not Applicable
Not yet recruiting
- Conditions
- Oesophageal CancerGastric CancerColorectal CancerDuodenal Cancer
- Interventions
- Other: mid-frequency whole-body electromyostimulation (WB-EMS)Other: conventional exercise trainingOther: nutritional therapy
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 88
- Registration Number
- NCT06414122
- Locations
- 🇩🇪
Universitätsklinikum Köln, Centrum für Integrierte Onkologie (CIO), Cologne, NRW, Germany